Determination 2 - Isatuximab, Iberdomide, Bortezomib and Dexamethasone Induction, Followed by Risk- and Response-Adapted Consolidation and Maintenance Therapy, in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma
PHASE3
The purpose of the study is to determine the best treatment approach based ...
Intensive Conditioning withTHI/Bu/Flu/Ara-C in Allo-HSCT for Myeloid Malignancies With Extramedullary Involvement
N/A
This study is a multicenter, single-arm, prospective phase II clinical tria...
Status
Recruiting
Location
Shanghai General Hospital
Start Date
2024-01-20
Trial ID
NCT06111612
Study of Melphalan HCl for Injection (Propylene Glycol-free), Carmustine, Etoposide, Cytarabine (BEAM Regimen) and Autologous Stem Cell Transplantation for Lymphoma
PHASE2
Phase II study is being conducted to confirm the safety and efficacy of hig...
Structural Imaging and Cognitive Functions in Adult Stem Cell Transplant Recipients Treated With Chemotherapy Alone or in Combination With Radiotherapy
N/A
The purpose of this study is to learn about possible changes in brain anato...